Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Other financing activities (2016 - 2025)

Historic Other financing activities for AtriCure (ATRC) over the last 16 years, with Q3 2025 value amounting to $6.2 million.

  • AtriCure's Other financing activities rose 922835.82% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 48465.86%. This contributed to the annual value of $1.1 million for FY2024, which is 168166.67% up from last year.
  • Latest data reveals that AtriCure reported Other financing activities of $6.2 million as of Q3 2025, which was up 922835.82% from $67000.0 recorded in Q3 2024.
  • AtriCure's Other financing activities' 5-year high stood at $10.2 million during Q2 2021, with a 5-year trough of -$6.3 million in Q3 2021.
  • Over the past 4 years, AtriCure's median Other financing activities value was $142000.0 (recorded in 2024), while the average stood at $950000.0.
  • Examining YoY changes over the last 5 years, AtriCure's Other financing activities showed a top increase of 11700000.0% in 2021 and a maximum decrease of 21445.3% in 2021.
  • Quarter analysis of 4 years shows AtriCure's Other financing activities stood at $1.2 million in 2021, then plummeted by 94.88% to $60000.0 in 2023, then grew by 11.67% to $67000.0 in 2024, then skyrocketed by 9228.36% to $6.2 million in 2025.
  • Its last three reported values are $6.2 million in Q3 2025, $67000.0 for Q3 2024, and $142000.0 during Q2 2024.